LicianPro

Scholar Rock Holding Corp ·

SRRK 8-K 2026-11-10

Scholar Rock Holding Corp (SRRK) 8-K dated 2026-11-10 — accession 0001193125-26-454423.

Scholar Rock Holding Corp (SRRK) is a biotechnology company listed on US.

SRRK: Scholar Rock Reports Third Quarter 2026 Financial Results and Recent Bu…

This 8-K covers: Material agreement (Item 1.01), Results of operations (Item 2.02), Reg FD disclosure (Item 7.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SRRK revenue for 2025-12-31 was $0. Net income was -$377.9M. Revenue was down 100.0% from 2022-12-31 to 2025-12-31. SRRK currently screens at market cap $3.42B.

Not investment advice. The SRRK SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

Guidance
guidance from the European Medicines Agency (EMA), Scholar Rock resubmitted the apitegromab Marketing Authorisation Application

Why it matters

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr